Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: Aug. 18, 2022‚Äč

Change to diagnosis of gestational diabetes helped some women. Using a lower threshold to diagnose the pregnancy-related condition hasn't reduced the risk of...

Nurse-Led Interventions May Cut Children's Fear of Needles

THURSDAY, Aug. 18, 2022 -- Two new nurse-led interventions to reduce negative impacts of vaccinations in children -- divided attention (DA) and positive memory...

Cutting 1 g Salt Per Day in China Could Save 4 Million Lives

THURSDAY, Aug. 18, 2022 -- Reducing the high salt intake levels in China could result in large declines in cardiovascular disease (CVD) events and death...

Cheap, Same-Day Test Could Help Spot Miscarriage Risk

THURSDAY, Aug. 18, 2022 -- A new and inexpensive same-day test could help pregnant women learn if their developing fetus has genetic problems that increase...

One-Third of YouTube Hay Fever Videos Are Misleading

THURSDAY, Aug. 18, 2022 -- Less than half of YouTube videos on allergic rhinitis provide useful information, according to a study published online July 13 in...

Pandemic Tied to Worse Pregnancy-Related Complications, Maternal Death

THURSDAY, Aug. 18, 2022 -- The first year of the COVID-19 pandemic was associated with increases in pregnancy-related complications and maternal deaths during...

Retinal Layer Thinning May Predict Relapse Remission in MS

THURSDAY, Aug. 18, 2022 -- Retinal layer thinning after optic neuritis (ON) may be useful as a marker of future relapse remission in relapsing multiple...

Taking a Shot at Pain Relief After Knee Replacement

THURSDAY, Aug. 18, 2022 -- Researchers may have found a new way to help ease the pain of knee replacement surgery: infusing morphine directly into the shin...

Hispanic Americans' Suicide Rates Are Rising

THURSDAY, Aug. 18, 2022 -- Suicide is a major public health issue for all Americans, but new research suggests it is a particularly pressing problem for...

AHA News: New Report Details What to Know About Cardiovascular Disease Symptoms

THURSDAY, Aug. 18, 2022 (American Heart Association News) -- Symptoms of cardiovascular problems run the gamut. Some – like chest pain during a heart attack or...

FDA Approves Zynteglo (betibeglogene autotemcel) Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusions

SOMERVILLE, Mass.--(BUSINESS WIRE)--Aug. 17, 2022-- bluebird bio, Inc. (Nasdaq: BLUE) today announced the U.S. Food and Drug Administration (FDA) has approved...

Enhertu Approved in the US as the First HER2-Directed Therapy for Patients with Previously Treated HER2-Mutant Metastatic Non-Small Cell Lung Cancer

Based on DESTINY-Lung02 results which showed AstraZeneca and Daiichi Sankyo’s Enhertu reported a confirmed objective response rate of 57.7% in patients...

Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer

Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2-...

Genentech Announces FDA Approval of Xofluza to Treat Influenza in Children Aged Five and Older

Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved for children as young as five years of age The FDA...

Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia

Reata Submitted New Data and Analyses to Address FDA Questions During Mid-Cycle Meeting FDA Extended PDUFA Date to Provide Time for Full Review of New...

Enhertu Approved in the US as the First HER2-Directed Therapy for Patients with HER2-Low Metastatic Breast Cancer

Based on DESTINY-Breast04 results which showed AstraZeneca and Daiichi Sankyo’s Enhertu reduced risk of disease progression or death by 50% and...

Calquence Tablet Formulation Approved in the US Across Current indications

New formulation can be co-administered with gastric acid-reducing agents Tablet offers equivalent efficacy, safety and consistent dosing compared to current...

Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review

If approved, omidubicel will be the first allogeneic advanced stem cell therapy donor source for patients with blood cancers in need of a stem cell...

Cidara Therapeutics Submits NDA for Rezafungin

Submitted NDA for rezafungin for candidemia and invasive candidiasis to the U.S. FDA on July 22, 2022, with an anticipated PDUFA target action date in the...

Lexicon Announces FDA Acceptance of New Drug Application for Sotagliflozin to Treat Heart Failure

The Woodlands, Texas, July 27, 2022 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has...

CSL Announces Positive Top-Line Phase 3 Results for Garadacimab as Preventive Treatment in Patients with Hereditary Angioedema

KING OF PRUSSIA, Pa., Aug. 17, 2022. Global biotechnology leader CSL today announced positive top-line Phase 3 results for garadacimab (CSL312), the company's...

Pneumagen Announces First Patient Dosed in Phase 2 Proof of Concept Influenza Challenge Study Assessing Neumifil, an Intranasal Broad-Spectrum Antiviral

ST ANDREWS, Scotland, Aug. 16, 2022. Pneumagen, a clinical stage biotech company developing Neumifil, an intranasal, broad-spectrum antiviral treatment to...

Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older

If authorized, Novavax' vaccine would be the first protein-based COVID-19 booster for adults If authorized, the Novavax COVID-19 Vaccine, Adjuvanted could...

Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial

SAN JOSE, Calif., Aug. 15, 2022. Anixa Biosciences, Inc. ("Anixa") a biotechnology company focused on the treatment and prevention of cancer and infectious...

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

Basel, 12 August 2022 - Roche today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.